AstraZeneca's Q3 profit jumped 23% on booming cancer drug sales

Statements (9)

1. ▲ Bullish

   AstraZeneca reported a better-than-expected earnings result

   finance.yahoo.comOct 30, 2026 18:12 UTCHigh importance
2. ▲ Bullish

   AstraZeneca's net profit jumped 23% in the third quarter on booming sales of its cancer drugs.

   euronews.comOct 30, 2026 12:17 UTCHigh importance
3. ▲ Bullish

   AstraZeneca reported a 23% increase in profit in the third quarter.

   valor.globo.comOct 30, 2026 12:00 UTCHigh importance
4. ▲ Bullish

   AstraZeneca reported strong earnings.

   nasdaq.comOct 30, 2026 10:58 UTC
5. ▲ Bullish

   Astra Zeneca reported higher-than-expected third-quarter profits

   di.seOct 30, 2026 09:50 UTCHigh importance
6. ▲ Bullish

   AstraZeneca reported a third-quarter profit of $3.12 billion, up from $2.53 billion in the prior year.

   nasdaq.comOct 30, 2026 07:52 UTCHigh importance
7. ▲ Bullish

   AstraZeneca reported net profit of $3.12 billion for the third quarter, up from $2.535 billion for the same period last year.

   wsj.comOct 30, 2026 07:38 UTCHigh importance
8. ▲ Bullish

   AstraZeneca's profit increased due to its blockbuster cancer drugs

   bloomberg.comOct 30, 2026 07:10 UTCHigh importance
9. ▲ Bullish

   AstraZeneca's Q3 revenue jumped 7% to $16.2 billion

   breakingthenews.netOct 30, 2026 07:03 UTCHigh importance